FDA approves two Aurobindo generics


The FDA has approved two Aurobindo generic drugs for manufacture and sale in the US market. The two drugs are Tranexamic acid injection and Paricalcitol capsules. Aurobindo will be launching the Tranexamic acid injection drug by the end of this fiscal year, while the Paricalcitol capsules are expected to launch in the first quarter of the next fiscal year.

Read the source article at The Economic Times

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>